Andrew R. Adams
Mairs & Power Growth Fund
Mairs & Power Growth Fund Pfizer Inc stake
total: 96
Mairs & Power Growth Fund PFE trades
- Total transactions:
- 6
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 4
- Held since:
- 2019 Q3
- Held for:
- 9 quarters
- Latest activity:
- 2021 Q4
According to 2026 Q2 report, Mairs & Power Growth Fund doesn't hold any Pfizer Inc (PFE) shares. To date, the estimated cost basis is nearly $35.93 for "buy" trades and estimated average "sell" price is $40.63. Mairs & Power Growth Fund first purchased PFE in 2019 Q3, initially acquiring about 1.46M shares. Since the initial investment in Pfizer Inc (PFE), Mairs & Power Growth Fund has made 5 more transactions.
When did Mairs & Power Growth Fund sell Pfizer Inc (PFE)?
Mairs & Power Growth Fund sold off the entire Pfizer Inc (PFE) position in 2021 Q4.
When did Mairs & Power Growth Fund buy Pfizer Inc (PFE)?
Mairs & Power Growth Fund first invested in Pfizer Inc (PFE) in 2019 Q3 at the reported quarter-end price of $35.93 per share.
What's the cost basis of Mairs & Power Growth Fund's PFE stake?
The estimated cost basis for Pfizer Inc (PFE) stake is around $35.93 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $35.93
- Weighted AVG sell price:
- $40.63
Mairs & Power Growth Fund's historical trades in Pfizer Inc
6 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q4
|
0.00%
|
0
|
$43.01
|
|
-100% (-762,000)
|
-0.6%
|
|
2021 Q3
|
0.60%
|
762,000
|
$43.01
|
$32,773,620
|
-24.55% (-248,000)
|
-0.19%
|
|
2020 Q4
|
0.77%
|
$36.81
|
-9.01% (-100,000)
|
|||
|
2020 Q3
|
0.93%
|
$36.70
|
-14.62% (-190,000)
|
|||
|
2020 Q2
|
1.02%
|
$32.70
|
-10.96% (-160,000)
|
|||
|
2019 Q3
|
1.20%
|
$35.93
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.